In this Healio Video Perspective, Charles C. Wykoff, MD, PhD, discusses 2-year results from the Archway study of Susvimo (ranibizumab injection, Genentech) to treat wet AMD, presented at Angiogenesis, Exudation, and Degeneration 2022.
Uncategorized
VIDEO: Two-year data show good visual, anatomic outcomes for Susvimo in wet AMD